Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Brain Pathology (Zurich, Switzerland)
|
July 19, 2012
LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells
Susumu Nakata, Benito Campos, Josephine Bageritz, et al.
Journal of Neuro-Oncology
|
April 25, 2012
No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas
Rezvan Ahmadi, Florian Stockhammer, Natalia Becker, et al.
Oncoimmunology
|
June 7, 2018
Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial
Judith Michels, Natalia Becker, Stefan Suciu, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
February 18, 2011
Association of stem cell-related markers and survival in astrocytic gliomas
Feng Wan, Christel Herold-Mende, Benito Campos, et al.
International Journal of Cancer
|
February 3, 2016
SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients
Elisabeth J Kap, Petra Seibold, Dominique Scherer, et al.
International Journal of Cancer
|
October 30, 2014
Identification of HERC5 and its potential role in NSCLC progression
Michaela Wrage, Wolfgang Hagmann, Dirk Kemming, et al.
Child and Adolescent Psychiatry and Mental Health
|
February 15, 2026
Motherhood in adolescence: a qualitative study of the lived experience of participants in a perinatal home-visiting intervention
Débora Tseng Chou, Emilio Abelama Neto, Lislaine Aparecida Fracolli, et al.
Haematologica
|
May 20, 2017
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up
Ute Hegenbart, Tilmann Bochtler, Axel Benner, et al.
International Journal of Cancer
|
May 18, 2010
Molecular signatures classify astrocytic gliomas by IDH1 mutation status
Grischa Toedt, Sebastian Barbus, Marietta Wolter, et al.
Journal of Mental Health (Abingdon, England)
|
May 12, 2021
Latent structure and factor reliability of the National Health Service Community Mental Health Service User Questionnaire
Mauricio Scopel Hoffmann, Katia Bones Rocha, Sara Evans-Lacko, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Brain Pathology (Zurich, Switzerland)
|
July 19, 2012
LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells
Susumu Nakata, Benito Campos, Josephine Bageritz, et al.
Journal of Neuro-Oncology
|
April 25, 2012
No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas
Rezvan Ahmadi, Florian Stockhammer, Natalia Becker, et al.
Oncoimmunology
|
June 7, 2018
Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial
Judith Michels, Natalia Becker, Stefan Suciu, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
February 18, 2011
Association of stem cell-related markers and survival in astrocytic gliomas
Feng Wan, Christel Herold-Mende, Benito Campos, et al.
International Journal of Cancer
|
February 3, 2016
SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients
Elisabeth J Kap, Petra Seibold, Dominique Scherer, et al.
International Journal of Cancer
|
October 30, 2014
Identification of HERC5 and its potential role in NSCLC progression
Michaela Wrage, Wolfgang Hagmann, Dirk Kemming, et al.
Child and Adolescent Psychiatry and Mental Health
|
February 15, 2026
Motherhood in adolescence: a qualitative study of the lived experience of participants in a perinatal home-visiting intervention
Débora Tseng Chou, Emilio Abelama Neto, Lislaine Aparecida Fracolli, et al.
Haematologica
|
May 20, 2017
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up
Ute Hegenbart, Tilmann Bochtler, Axel Benner, et al.
International Journal of Cancer
|
May 18, 2010
Molecular signatures classify astrocytic gliomas by IDH1 mutation status
Grischa Toedt, Sebastian Barbus, Marietta Wolter, et al.
Journal of Mental Health (Abingdon, England)
|
May 12, 2021
Latent structure and factor reliability of the National Health Service Community Mental Health Service User Questionnaire
Mauricio Scopel Hoffmann, Katia Bones Rocha, Sara Evans-Lacko, et al.
Page
of 5